AFP

AFT Pharmaceuticals Limited

1 day chart

About AFP

AFT Pharmaceuticals Limited (AFP) is a multinational pharmaceutical business with a range of products, both developed itself and in-licensed from third parties. AFT's products cover all major pharmaceutical distribution channels: over the counter, prescription and hospital. Its featured brand includes- Crystaderm, coco-scalp and maxigesic.

Buy Australian shares starting with AFP. Invest today with a CHESS-sponsored investing platform!

Sector

Health Care

CEO

Industry

Pharmaceuticals

Website

aftpharm.com

Market Capitalisation

$354M

Price-earnings ratio

36.11

Dividend yield

0.20%

High today

$3.38

Low today

$3.38

Open price

$3.38

52-week high

$3.70

52-week low

$2.90

Announcements

AFP FAQs

Can I buy AFP shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy AFP shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of AFT Pharmaceuticals Limited?

One share of AFT Pharmaceuticals Limited is valued at $3.38.

What is the ticker symbol for AFT Pharmaceuticals Limited?

The ticker symbol for AFT Pharmaceuticals Limited is AFP.

How do I buy AFP shares in Australia?

To buy AFP stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake AUS
Deposit directly into your Stake wallet and you're ready to invest in AFP

What is the 52-week high for AFT Pharmaceuticals Limited stock?

The AFT Pharmaceuticals Limited 52-week high stock price is $3.70.

What is the 52-week low for AFT Pharmaceuticals Limited stock?

The AFT Pharmaceuticals Limited 52-week low stock price is $2.90.

What is the market capitalisation of AFT Pharmaceuticals Limited AFP?

As of 29/09/2023 AFT Pharmaceuticals Limited has a market cap of $354M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.